Facial And Oral Manifestations Following COVID-19 Vaccination

Abstract

Background: In late 2019, the severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), also referred to as the COVID-19 by the general populous, was discovered in Wuhan, China. The discovery of efficacious SARS-CoV-2 vaccines has been incredibly swift. Based on clinical trials, orofacial side effects of BNT162b2 and mRNA-1452 vaccinations are believed to be uncommon. The goal of this survey-based study was to look at the face and oral symptoms of COVID-19 vaccination.

Methods: The survey was designed using Google Forms and disseminated anonymously to 900 medical personnel.

Results: 403 individuals, mostly BNT162b2 vaccine recipients, responded to the survey. Only 3.1 percent and 5.4 percent, respectively, had oral and facial problems. The presence of general disorders and age have a substantial impact on the likelihood of developing oral complaints following the second dose. Medication adherence, gender and tobacco use all have an impact on the likelihood of taking a sick day. The duration of symptoms after the second dose is affected by gender, age, and smoking.

Conclusion: According to the findings of this exploratory study, there is no evidence of a link between COVID-19 vaccination administration and facial or oral signs.